4.5 Article

Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study

Journal

AGING CLINICAL AND EXPERIMENTAL RESEARCH
Volume 34, Issue 10, Pages 2441-2448

Publisher

SPRINGER
DOI: 10.1007/s40520-022-02214-9

Keywords

Acrylamide; Fracture; Osteoporosis; Osteoarthritis initiative

Funding

  1. Universita degli Studi di Palermo within the CRUI-CARE Agreement
  2. University of Palermo
  3. National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]
  4. Merck Research Laboratories
  5. Novartis Pharmaceuticals Corporation
  6. GlaxoSmithKline
  7. Pfizer, Inc.
  8. Foundation for the National Institutes of Health

Ask authors/readers for more resources

This study is the first to report that high dietary acrylamide may be associated with an increased risk of osteoporotic fractures.
Background Acrylamide, a component of fried foods, has been associated with several negative health outcomes. However, the relationship between dietary acrylamide and osteoporotic fractures has been explored by a few cross-sectional studies. Aims To investigate if dietary acrylamide is associated with the onset of fractures in North American participants at high risk/having knee osteoarthritis (OA), over 8 years of follow-up. Methods A Cox's regression analysis, adjusted for baseline confounders was run and the data were reported as hazard ratios (HRs) and 95% confidence intervals (CIs). Dietary acrylamide intake was assessed at the baseline using a food frequency questionnaire and categorized in tertiles (T), whilst fractures' history was recorded using self-reported information. Results Altogether, 4,436 participants were included. Compared to participants with lower acrylamide intake (T1; < 3,313 mu g), those with a higher acrylamide intake (T3; > 10,180 mu g) reported a significantly higher risk of any fracture (HR = 1.37; 95% CI 1.12-1.68; p for trend = 0.009), forearm (HR = 1.73; 95% CI 1.09-2.77; p for trend = 0.04), spine (HR = 2.21; 95% CI 1.14-4.31; p for trend = 0.04), and hip fracture (HR = 4.09; 95% CI 1.29-12.96; p for trend = 0.046). Conclusions Our study is the first to report that high dietary acrylamide may be associated with an increased risk of osteoporotic fractures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available